---
schema_version: "secwatch.filing_event.v1"
accession: "0001740797-24-000047"
form_type: "8-K"
ticker: "AVAI"
cik: "0001740797"
company_name: "AVAI BIO, INC."
filed_at: "2024-09-10T23:59:59+00:00"
generated_at: "2026-05-31T05:40:21.897737+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Avant Tech terminates $2.2M Wired4Health asset purchase; CFO replaced

## Summary
- APA with Wired4Health for $2.2M consideration cancelled; remaining promissory note balance void.
- Payments already made retained by Wired4Health; both parties mutually released from all claims.
- CFO William Hisey resigned Sept 9, 2024; COO Vitalis Racius appointed CFO, retains other roles.
- No conflicts reported with Hisey's departure.

## SEC filing metadata
- accession: 0001740797-24-000047
- form_type: 8-K
- ticker: AVAI
- cik: 0001740797
- company_name: AVAI BIO, INC.
- filed_at: 2024-09-10T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000047/0001740797-24-000047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000047/avai_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001740797-24-000047
- JSON: https://secwatch.observer/filing/0001740797-24-000047.json
- Plain text: https://secwatch.observer/filing/0001740797-24-000047.txt

## Key facts
- Executive change
  William Hisey resigned as Chief Financial Officer at AVAI BIO, INC..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: Effective September 9, 2024, Mr. Hisey vacated his position as Chief Financial Officer (the “CFO”) of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000047/0001740797-24-000047-index.htm
- Executive change
  Vitalis Racius was appointed as Chief Financial Officer at AVAI BIO, INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Mr. Racius, the current Chief Operating Officer (the “COO”), Director, and Treasurer, was reappointed as the Company's Chief Financial Officer (the “CFO”) while continuing his roles as Director and Treasurer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1740797/000174079724000047/0001740797-24-000047-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.